Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
Open Access
- 1 January 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 11 (1) , 88-95
- https://doi.org/10.1002/jbmr.5650110113
Abstract
Chronic immune responses and inflammatory reactions in rheumatoid arthritis (RA) often cause severe destruction of cartilage and bone, but its mechanism is still a matter of controversy. We reported that interleukin-6 (IL-6) alone does not induce osteoclast formation, but soluble interleukin-6 receptors (sIL-6R) triggered the formation in the presence of IL-6 in cocultures of murine osteoblastic cells and bone marrow cells. In this study, we examined the involvement of sIL-6R and IL-6 in joint destruction in patients with RA. Although the frequency of patients having osteoclast-like multinucleated cells in synovium derived from the knee joint was not significantly different between RA (65%) and osteoarthritis (OA) patients (43%), the number of osteoclast-like cells found in the synovium was greater in the former than in the latter. Multinucleated cells obtained from RA synovium expressed the osteoclast-specific phenotype such as tartrate-resistant acid phosphatase, carbonic anhydrase II, vacuolar proton-ATPase and vitronectin receptors at similar levels to those from a human giant cell tumor of bone. The concentration of both IL-6 and sIL-6R was significantly higher in the synovial fluids from patients with RA than with OA. The concentration of IL-6 and sIL-6R correlated well with the roentgenologic grades of joint destruction. Dose-response curves for human IL-6 and human sIL-6R in inducing osteoclast-like cell formation in cocultures indicated that the RA synovial fluids contained sufficient IL-6 and sIL-6R to induce osteoclastogenesis. When synovial fluids from RA and OA patients were added to the cocultures, some of the RA synovial fluids containing high levels of IL-6 and sIL-6R stimulated osteoclast-like cell formation, which was strikingly inhibited by adding anti-IL-6R antibody simultaneously. These results suggest that IL-6 in the RA synovial fluids is at least in part responsible for joint destruction in the presence of sIL-6R through osteoclastogenesis.Keywords
Funding Information
- Scientific Research of the Ministry of Education
- Science and Culture of Japan ((5770330))
This publication has 34 references indexed in Scilit:
- Localisation of vitronectin receptor immunoreactivity and tartrate resistant acid phosphatase activity in synovium from patients with inflammatory or degenerative arthritis.Annals of the Rheumatic Diseases, 1993
- Preparation and characterization of a mouse osteoclast-like multinucleated cell populationJournal of Bone and Mineral Research, 1992
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- Perspectives: Interleukin-6: An osteotropic factor?Journal of Bone and Mineral Research, 1992
- Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariaeJournal of Bone and Mineral Research, 1991
- Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synoviumClinical Immunology and Immunopathology, 1989
- Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesisBiochemical and Biophysical Research Communications, 1989
- New perspectives on the pathogenesis of rheumatoid arthritisThe American Journal of Medicine, 1988
- Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritidesArthritis & Rheumatism, 1988
- Augmented interleukin‐1 production and hla–dr expression in the synovium of rheumatoid arthritis patientsArthritis & Rheumatism, 1988